• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
13th st. Gallen international breast cancer conference 2013: primary therapy of early breast cancer evidence, controversies, consensus - opinion of a german team of experts (zurich 2013).第 13 届圣加仑国际乳腺癌会议 2013 年:早期乳腺癌的主要治疗方法——证据、争议、共识——德国专家组意见(2013 年苏黎世)。
Breast Care (Basel). 2013 Jun;8(3):221-9. doi: 10.1159/000351692.
2
Primary Therapy of Patients with Early Breast Cancer: Evidence, Controversies, Consensus: Opinions of German Specialists to the 14th St. Gallen International Breast Cancer Conference 2015 (Vienna 2015).早期乳腺癌患者的初始治疗:证据、争议与共识:德国专家对2015年第14届圣加仑国际乳腺癌会议(2015年维也纳)的观点
Geburtshilfe Frauenheilkd. 2015 Jun;75(6):556-565. doi: 10.1055/s-0035-1546120. Epub 2015 Jun 17.
3
14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts.2015年第14届圣加仑国际乳腺癌大会:证据、争议与共识——早期乳腺癌的初始治疗:德国专家观点
Breast Care (Basel). 2015 Jul;10(3):211-9. doi: 10.1159/000433590. Epub 2015 Jun 23.
4
Primary Therapy of Early Breast Cancer: Evidence, Controversies, Consensus: Spectrum of Opinion of German Specialists on the 16th St. Gallen International Breast Cancer Conference (Vienna 2019).早期乳腺癌的主要治疗方法:证据、争议与共识:德国专家对第16届圣加仑国际乳腺癌会议(2019年维也纳)的观点综述
Geburtshilfe Frauenheilkd. 2019 Jun;79(6):591-604. doi: 10.1055/a-0897-6457. Epub 2019 Jun 14.
5
Treatment of Early Breast Cancer Patients: Evidence, Controversies, Consensus: Focusing on Systemic Therapy - German Experts' Opinions for the 16th International St. Gallen Consensus Conference (Vienna 2019).早期乳腺癌患者的治疗:证据、争议与共识:聚焦全身治疗——德国专家为第16届国际圣加仑共识会议(2019年维也纳)提供的意见
Breast Care (Basel). 2019 Oct;14(5):315-324. doi: 10.1159/000502603. Epub 2019 Sep 17.
6
Initial Treatment of Patients with Primary Breast Cancer: Evidence, Controversies, Consensus: Spectrum of Opinion of German Specialists at the 15th International St. Gallen Breast Cancer Conference (Vienna 2017).原发性乳腺癌患者的初始治疗:证据、争议、共识:第15届国际圣加仑乳腺癌会议(2017年维也纳)上德国专家的观点范围
Geburtshilfe Frauenheilkd. 2017 Jun;77(6):633-644. doi: 10.1055/s-0043-111601. Epub 2017 Jun 28.
7
Zurich Consensus: German Expert Opinion on the St. Gallen Votes on 15 March 2009 (11th International Conference at St. Gallen: Primary Therapy of Early Breast Cancer).苏黎世共识:2009年3月15日德国专家对圣加仑投票的意见(第11届圣加仑国际早期乳腺癌原发性治疗会议)
Breast Care (Basel). 2009;4(2):109-116. doi: 10.1159/000212164. Epub 2009 Apr 24.
8
Practice-Changing Perspectives regarding Systemic Therapy in Early Breast Cancer: Opinions of German Experts regarding the 17th St. Gallen International Consensus Conference.早期乳腺癌全身治疗的观念转变:德国专家对第17届圣加仑国际共识会议的看法
Breast Care (Basel). 2022 Jun;17(3):336-345. doi: 10.1159/000517501. Epub 2022 Apr 8.
9
Treatment of Early Breast Cancer: The 18th St. Gallen International Breast Cancer Consensus Conference against the Background of Current German Treatment Recommendations.早期乳腺癌的治疗:在当前德国治疗建议背景下召开的第18届圣加仑国际乳腺癌共识会议
Geburtshilfe Frauenheilkd. 2023 Sep 12;83(9):1102-1116. doi: 10.1055/a-2121-2495. eCollection 2023 Sep.
10
Treatment of Patients with Early Breast Cancer: Evidence, Controversies, Consensus: German Expert Opinions on the 17th International St. Gallen Consensus Conference.早期乳腺癌患者的治疗:证据、争议、共识:德国专家对第17届国际圣加仑共识会议的看法
Geburtshilfe Frauenheilkd. 2021 Jun;81(6):637-653. doi: 10.1055/a-1483-2782. Epub 2021 May 19.

引用本文的文献

1
Breast Cancer Recurrence in Initially Clinically Node-Positive Patients Undergoing Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in the NEOSENTITURK-Trials MF18-02/18-03.在NEOSENTITURK试验MF18 - 02/18 - 03中,接受新辅助化疗后进行前哨淋巴结活检的初始临床淋巴结阳性患者的乳腺癌复发情况。
Ann Surg Oncol. 2025 Feb;32(2):952-966. doi: 10.1245/s10434-024-16472-6. Epub 2024 Dec 2.
2
Combined analysis of the MF18-02/MF18-03 NEOSENTITURK studies: ypN-positive disease does not necessitate axillary lymph node dissection in patients with breast cancer with a good response to neoadjuvant chemotherapy as long as radiotherapy is provided.MF18 - 02/MF18 - 03 NEOSENTITURK研究的联合分析:对于新辅助化疗反应良好的乳腺癌患者,只要进行放疗,ypN阳性疾病并不一定需要腋窝淋巴结清扫。
Cancer. 2025 Jan 1;131(1):e35610. doi: 10.1002/cncr.35610. Epub 2024 Oct 30.
3
Impact of Molecular Profiling on Therapy Management in Breast Cancer.分子谱分析对乳腺癌治疗管理的影响
J Clin Med. 2024 Aug 23;13(17):4995. doi: 10.3390/jcm13174995.
4
Predictive value of MRI-based deep learning model for lymphovascular invasion status in node-negative invasive breast cancer.基于 MRI 的深度学习模型对淋巴结阴性浸润性乳腺癌淋巴管血管侵犯状态的预测价值。
Sci Rep. 2024 Jul 13;14(1):16204. doi: 10.1038/s41598-024-67217-0.
5
Targeted axillary dissection reduces residual nodal disease in clinically node- positive breast cancer after neoadjuvant chemotherapy.新辅助化疗后临床淋巴结阳性乳腺癌行靶向腋窝清扫术可减少残留淋巴结疾病。
World J Surg Oncol. 2024 Jul 6;22(1):178. doi: 10.1186/s12957-024-03413-6.
6
Alteration of the immune microenvironment in the axillary metastatic lymph nodes of luminal A breast cancer patients.腔面 A 型乳腺癌患者腋窝转移性淋巴结免疫微环境的改变。
World J Surg Oncol. 2024 Jun 27;22(1):172. doi: 10.1186/s12957-024-03454-x.
7
Breast cancer in northern Peru: molecular subtypes and HER2 low.秘鲁北部的乳腺癌:分子亚型与 HER2 低表达。
Rev Peru Med Exp Salud Publica. 2024 May 27;41(1):62-68. doi: 10.17843/rpmesp.2024.411.13424.
8
A prismatic view of the epigenetic-metabolic regulatory axis in breast cancer therapy resistance.乳腺癌治疗耐药性中表观遗传-代谢调控轴的多棱镜观点。
Oncogene. 2024 Jun;43(23):1727-1741. doi: 10.1038/s41388-024-03054-9. Epub 2024 May 8.
9
The global landscape and research trend of lymphangiogenesis in breast cancer: a bibliometric analysis and visualization.乳腺癌淋巴管生成的全球格局与研究趋势:文献计量分析与可视化
Front Oncol. 2024 Mar 14;14:1337124. doi: 10.3389/fonc.2024.1337124. eCollection 2024.
10
Correlation between Histopathological Prognostic Tumor Characteristics and [F]FDG Uptake in Corresponding Metastases in Newly Diagnosed Metastatic Breast Cancer.新诊断的转移性乳腺癌组织病理学预后肿瘤特征与相应转移灶中[F]FDG摄取之间的相关性
Diagnostics (Basel). 2024 Feb 14;14(4):416. doi: 10.3390/diagnostics14040416.

本文引用的文献

1
Identification and Resection of Clipped Node Decreases the False-negative Rate of Sentinel Lymph Node Surgery in Patients Presenting With Node-positive Breast Cancer (T0-T4, N1-N2) Who Receive Neoadjuvant Chemotherapy: Results From ACOSOG Z1071 (Alliance).识别并切除夹闭淋巴结可降低接受新辅助化疗的淋巴结阳性乳腺癌(T0-T4,N1-N2)患者前哨淋巴结手术的假阴性率:美国外科医师学会肿瘤学组Z1071(联盟)研究结果
Ann Surg. 2016 Apr;263(4):802-7. doi: 10.1097/SLA.0000000000001375.
2
Agreement in risk prediction between the 21-gene recurrence score assay (Oncotype DX®) and the PAM50 breast cancer intrinsic Classifier™ in early-stage estrogen receptor-positive breast cancer.21 基因复发评分检测(Oncotype DX®)与 PAM50 乳腺癌内在分类器™在早期雌激素受体阳性乳腺癌中的风险预测一致性。
Oncologist. 2012;17(4):492-8. doi: 10.1634/theoncologist.2012-0007. Epub 2012 Mar 14.
3
Favorable prognosis in patients with T1a/T1bN0 triple-negative breast cancers treated with multimodality therapy.多模态治疗治疗 T1a/T1bN0 三阴性乳腺癌患者的预后良好。
Cancer. 2012 Oct 15;118(20):4944-52. doi: 10.1002/cncr.27480. Epub 2012 Mar 5.
4
Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial.腋窝清扫与保留腋窝在伴有前哨淋巴结转移的浸润性乳腺癌女性中的随机临床试验
JAMA. 2011 Feb 9;305(6):569-75. doi: 10.1001/jama.2011.90.
5
Intense dose-dense sequential chemotherapy with epirubicin, paclitaxel, and cyclophosphamide compared with conventionally scheduled chemotherapy in high-risk primary breast cancer: mature results of an AGO phase III study.密集剂量序贯化疗联合表柔比星、紫杉醇和环磷酰胺与高危原发性乳腺癌常规化疗方案的比较:AGO Ⅲ期研究的成熟结果。
J Clin Oncol. 2010 Jun 10;28(17):2874-80. doi: 10.1200/JCO.2009.24.7643. Epub 2010 May 10.
6
Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel.使用五生物标志物组合预测早期浸润性乳腺癌保乳治疗后的局部复发、远处转移和死亡情况。
J Clin Oncol. 2009 Oct 1;27(28):4701-8. doi: 10.1200/JCO.2008.21.7075. Epub 2009 Aug 31.
7
Endocrine therapy plus zoledronic acid in premenopausal breast cancer.绝经前乳腺癌的内分泌治疗加唑来膦酸
N Engl J Med. 2009 Feb 12;360(7):679-91. doi: 10.1056/NEJMoa0806285.

第 13 届圣加仑国际乳腺癌会议 2013 年:早期乳腺癌的主要治疗方法——证据、争议、共识——德国专家组意见(2013 年苏黎世)。

13th st. Gallen international breast cancer conference 2013: primary therapy of early breast cancer evidence, controversies, consensus - opinion of a german team of experts (zurich 2013).

机构信息

Klinik für Gynäkologie und Geburtshilfe, interdisziplinäres Brustzentrum, HELIOS Klinikum Berlin Buch, Germany.

Universitätsfrauenklinik Rostock, Germany.

出版信息

Breast Care (Basel). 2013 Jun;8(3):221-9. doi: 10.1159/000351692.

DOI:
10.1159/000351692
PMID:24415975
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3728634/
Abstract

The International Consensus Conference on the treatment of primary breast cancer takes place every two years in St. Gallen, Switzerland. The panel in St. Gallen is composed of international experts from different countries. From a German perspective, it seems reasonable to interpret the voting results in the light of AGO-recommendations and S3-guidelines for everyday practice in Germany. Consequently, a team of eight breast cancer experts, of whom two are members of the international St. Gallen panel, commented on the voting results of the St. Gallen Consensus Conference (2013). The main topics at this year's St. Gallen conference were surgical issues of the breast and axilla, radio-therapeutic and systemic treatment options, and the clinical relevance of tumour biology. The clinical utility of multigene assays for supporting individual treatment decisions was also intensively discussed.

摘要

每两年在瑞士圣加仑举行一次原发性乳腺癌治疗国际共识会议。圣加仑小组由来自不同国家的国际专家组成。从德国的角度来看,根据 AGO 建议和德国日常实践的 S3 指南来解释投票结果似乎是合理的。因此,一个由八名乳腺癌专家组成的团队,其中两名是国际圣加仑小组的成员,对圣加仑共识会议(2013 年)的投票结果进行了评论。今年圣加仑会议的主要议题是乳房和腋窝的外科问题、放射治疗和系统治疗选择,以及肿瘤生物学的临床相关性。多基因检测在支持个体化治疗决策中的临床应用也进行了深入讨论。